Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis: Single and Multiple Oral Doses

NCT00418847 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT00418847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00418847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis: Single and Multiple Oral Doses
Lead sponsor
The Hospital for Sick Children
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2004
Completion date
April 30, 2009
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gangliosidoses gm2